IDSA COVID-19 Guidelines co-authors Rajesh Gandhi, MD, FIDSA and Adarsh Bhimraj, MD, FIDSA provide the latest information on COVID-19 treatments, including the potential role of combination therapies, newer therapies such as nirmatrelvir and strovimab, and their thoughts on President Biden's "Test to Treat" initiative. 

 

This holiday season, you can help strengthen the infectious diseases workforce and support the people who advance patient care and public health every day. All donations to the IDSA Foundation through December 31 are matched up to $50,000. Learn more and double your impact at idsafoundation.org.